UK markets closed
  • FTSE 100

    7,532.01
    +47.66 (+0.64%)
     
  • FTSE 250

    19,931.53
    +81.71 (+0.41%)
     
  • AIM

    953.45
    -1.84 (-0.19%)
     
  • GBP/EUR

    1.1759
    +0.0087 (+0.74%)
     
  • GBP/USD

    1.2539
    +0.0007 (+0.05%)
     
  • BTC-GBP

    23,642.07
    +301.78 (+1.29%)
     
  • CMC Crypto 200

    658.95
    -12.05 (-1.80%)
     
  • S&P 500

    3,956.60
    +15.12 (+0.38%)
     
  • DOW

    31,948.73
    +20.11 (+0.06%)
     
  • CRUDE OIL

    110.01
    +0.24 (+0.22%)
     
  • GOLD FUTURES

    1,847.80
    -17.60 (-0.94%)
     
  • NIKKEI 225

    26,677.80
    -70.34 (-0.26%)
     
  • HANG SENG

    20,171.27
    +59.17 (+0.29%)
     
  • DAX

    14,034.97
    +115.22 (+0.83%)
     
  • CAC 40

    6,309.61
    +56.47 (+0.90%)
     

Point-of-Care, Biosensors and Mobile Diagnostics Conference Europe 2022: Overview of POC Testing Landscape, from Novel Technologies to Regulatory Approval - Rotterdam, Netherlands - June 21-22, 2022

·2-min read
Company Logo
Company Logo

Dublin, May 12, 2022 (GLOBE NEWSWIRE) -- The "Point-of-Care, Biosensors and Mobile Diagnostics Europe 2022" conference has been added to ResearchAndMarkets.com's offering.

This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval.

The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Emphasis will be placed on mobile diagnostics platforms and convergence with microfluidics-based and lab-on-a-chip approaches.

Point-of-Care, Biosensors & Mobile Diagnostics Europe 2022 to be held on-site as a standard physical conference at the Hilton Rotterdam brings together the key opinion leaders from both academia and industry, this annual conference will discuss the expanding Point-of-Care Diagnostics and Biosensors fields and provide the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.

Agenda:

  • Biosensors

  • Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications

  • Low Cost POC Diagnostics Platforms for Deployment Worldwide

  • Next Generation Technologies for Pathogen Detection: Pandemics and Biosurveillance

  • Rapid Biodetection of Pathogens and Threat Identification: Pandemics and Biosurveillance

  • SARS-CoV-2 Rapid Diagnostics and Global Health

  • Wearable and Implantable Devices and Mobile Diagnostics Platforms/Devices

Speakers

Keynote Speakers

Holger Schmidt
Narinder Kapany Professor of Electrical Engineering, University of California-Santa Cruz

Marloes Peeters
Deputy Director of Chemical Engineering, Newcastle University

Arben Merkoci
ICREA Professor and Director of the Nanobioelectronics & Biosensors Group, Institut Catala de Nanociencia i Nanotecnologia (ICN2), Barcelona Institute of Science and Technology (BIST)

Karolien De Wael
Full Professor, Antwerp University

For more information about this conference visit https://www.researchandmarkets.com/r/tif2sh


CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting